from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2458/mmuM

LFCtreatmentdescriptionclass of inhibitor

-0.458

Amikacinug/mL Amikacintranslation

0.267

Cap5-10ug/mL Capreomycintranslation

-0.178

Rox10-50 ug/mL Roxithromycintranslation

-0.016

SM2-5 ug/mL Streptomycintranslation

0.174

Tet5-10 ug/mL Tetracyclinetranslation

-0.527

Rif0.2-5ug/mL Rifampicintranscription

-1.680

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.417

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.060

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.125

CPZ10-50 ug/mL Chlorpromazinerespiration

1.552

Clofazimine10-13 ug/mL Clofaziminerespiration

0.119

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.658

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.229

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.615

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.498

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.308

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.737

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.749

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.531

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.229

KCN5-20 ug/mL Potassium cyaniderespiration

-0.458

NaN30.2-2 mM Sodium aziderespiration

1.372

Nigericin50 uM Nigericinrespiration

-0.338

TRC10-150 ug/mL Triclosanrespiration

0.740

TRZ10-25 ug/mL Thioridazinerespiration

0.018

Valinomycin0.5-10 uM Valinomycinrespiration

1.758

ZnSO42 mM ZnSO4respiration

0.624

menadione6-10 ug/mL Menadionerespiration

0.114

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.280

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.785

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.522

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.848

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.283

Cephalexin20-100 ug/mL CephalexincellWall

-0.224

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.320

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.245

EMB10-20 ug/mL EthambutolcellWall

0.105

Eta12-40 ug/mL EthionamidecellWall

0.133

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.314

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.538

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.322

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.256

BZA0.12 mg/mL BenzamidearomaticAmides

-0.647

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.373

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.515

H2O24 mM hydrogen peroxideDNAdamaging

-0.546

Levo10 ug/mL LevofloxacinDNAdamaging

-0.094

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.647

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.547

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.053

UVUV-irradiationDNAdamaging

0.890

ARP41-4 ug/mL Antitubercular compound ARP4?

0.196

Antimycin12.5-50 ug/mL Antimycin A?

0.491

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.548

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.030

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.012

PA8240.2-2 ug/mL PA-824?

0.053

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.160

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.605

Verapamil50 uM Verapamil?

0.215

mercaptoethanol2 mM 2-Mercaptoethanol?

0.376

methoxatin10-20 ug/mL Methoxatin?